ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P ASX 200
8,555.80
0.19%
S&P ASX All Technology
4,107.60
0.90%
Brent Oil
74.39
0.00%
US Dollar vs AUD
1.57356
0.00%
Bitcoin
97,260.20
-0.34%
Pepperstone
Advertisement
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NYSE

  6. Ginkgo Bioworks Holdings Inc (DNA) Share Price

Ginkgo Bioworks Holdings Inc

Ginkgo Bioworks Holdings Inc (DNA)

Donaco International Ltd
14.73
1.18
(8.71%)
Closed 16 February 8:00AM
Delayed by 15 minutes
14.69
-0.04
(-0.27%)
After Hours: 11:59AM
Delayed by 15 minutes

Professional-Grade Tools, for Individual Investors.

Premium

Key stats and details

Current Price
14.69
Bid
-
Offer
-
Volume
2,873,205
13.92 Day's Range 15.33
5.26 52 Week Range 64.40
Market Cap
844.365M
Previous Close
13.55
Open
14.00
Last Trade
130
@
14.69
(formt)
Last Trade Time
Financial Volume
US$ 42,495,469
VWAP
14.7903
Average Volume (3m)
1,467,326
Shares Outstanding
57,478,905
Dividend Yield
-
PE Ratio
-0.95
Earnings Per Share (EPS)
-15.53
Revenue
251.46M
Net Profit
-892.87M

About Ginkgo Bioworks Holdings Inc

Ginkgo Bioworks Holdings Inc is building a platform to enable customers to program cells as easily to program computers. The company's platform is market agnostic and enables biotechnology applications across diverse markets, from food and agriculture to industrial chemicals to pharmaceuticals. Ginkgo Bioworks Holdings Inc is building a platform to enable customers to program cells as easily to program computers. The company's platform is market agnostic and enables biotechnology applications across diverse markets, from food and agriculture to industrial chemicals to pharmaceuticals.

Sector
Biological Pds,ex Diagnstics
Industry
Blank Checks
Website
www.ginkgobioworks.com
Headquarters
Wilmington, Delaware, USA
Founded
2021
Ginkgo Bioworks Holdings Inc is listed in the Biological Pds,ex Diagnstics sector of the New York Stock Exchange with ticker DNA. The last closing price for Ginkgo Bioworks was US$13.55. Over the last year, Ginkgo Bioworks shares have traded in a share price range of US$ 5.26 to US$ 64.40.

Ginkgo Bioworks currently has 57,478,905 shares in issue. The market capitalisation of Ginkgo Bioworks is US$778.84 million. Ginkgo Bioworks has a price to earnings ratio (PE ratio) of -0.95.

Ask ADVFN Intelligence (AI)

DNA Latest News

More News

Form 144 - Report of proposed sale of securities
Edgar (US Regulatory)
13 February 2025
DNA (8.71%)

Form 144 - Report of proposed sale of securities
Edgar (US Regulatory)
12 February 2025
DNA (8.71%)

Form 144 - Report of proposed sale of securities
Edgar (US Regulatory)
07 February 2025
DNA (8.71%)

Form 144 - Report of proposed sale of securities
Edgar (US Regulatory)
03 January 2025
DNA (8.71%)

Form 144 - Report of proposed sale of securities
Edgar (US Regulatory)
01 January 2025
DNA (8.71%)

Form 144 - Report of proposed sale of securities
Edgar (US Regulatory)
31 December 2024
DNA (8.71%)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.785.6074766355113.9114.991211.21169085313.22164449CS
44.3842.483026188210.3116.859.99166777013.35320214CS
128.14124.274809166.5516.856.5146732611.19280575CS
263.52231.536532951311.16816.855.2632666059.34522127CS
52-40.51-73.387681159455.264.45.262405015124.83706761CS
156-198.11-93.0968045113212.8222.45.262273814766.58851079CS
260-434.91-96.7326512456449.6634.565.262121107784.16565188CS

DNA - Frequently Asked Questions (FAQ)

What is the current Ginkgo Bioworks share price?
The current share price of Ginkgo Bioworks is US$ 14.69
How many Ginkgo Bioworks shares are in issue?
Ginkgo Bioworks has 57,478,905 shares in issue
What is the market cap of Ginkgo Bioworks?
The market capitalisation of Ginkgo Bioworks is USD 778.84M
What is the 1 year trading range for Ginkgo Bioworks share price?
Ginkgo Bioworks has traded in the range of US$ 5.26 to US$ 64.40 during the past year
What is the PE ratio of Ginkgo Bioworks?
The price to earnings ratio of Ginkgo Bioworks is -0.95
What is the cash to sales ratio of Ginkgo Bioworks?
The cash to sales ratio of Ginkgo Bioworks is 3.37
What is the reporting currency for Ginkgo Bioworks?
Ginkgo Bioworks reports financial results in USD
What is the latest annual turnover for Ginkgo Bioworks?
The latest annual turnover of Ginkgo Bioworks is USD 251.46M
What is the latest annual profit for Ginkgo Bioworks?
The latest annual profit of Ginkgo Bioworks is USD -892.87M
What is the registered address of Ginkgo Bioworks?
The registered address for Ginkgo Bioworks is CORPORATION TRUST CENTER, 1209 ORANGE ST, WILMINGTON, DELAWARE, 19801
What is the Ginkgo Bioworks website address?
The website address for Ginkgo Bioworks is www.ginkgobioworks.com
Which industry sector does Ginkgo Bioworks operate in?
Ginkgo Bioworks operates in the BLANK CHECKS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
NUSNu Skin Enterprises Inc
US$ 7.55
(17.60%)
3.59M
PCORProcore Technologies Inc
US$ 87.50
(16.51%)
4.58M
LANVLanvin Group Holdings Limited
US$ 1.85
(16.35%)
64.01k
ZHZhihu Inc
US$ 5.31
(15.43%)
4.06M
CAECae Inc
US$ 26.8085
(14.03%)
1.85M
GWHESS Tech Inc
US$ 4.01
(-26.96%)
330.85k
INFAInformatica Inc
US$ 19.75
(-21.53%)
27.95M
SASeabridge Gold Inc
US$ 11.28
(-15.38%)
3.54M
TWLOTwilio Inc
US$ 125.17
(-15.01%)
15.5M
HLHecla Mining Company
US$ 5.42
(-14.91%)
33.12M
BBAIBigBear ai Holdings Inc
US$ 9.015
(-7.82%)
84.26M
NIONIO Inc
US$ 4.43
(3.99%)
54.3M
FFord Motor Company
US$ 9.4701
(1.28%)
53.78M
BABAAlibaba Group Holding Limited
US$ 124.73
(4.34%)
52.74M
QBTSD Wave Quantum Inc
US$ 6.37
(-2.00%)
52.14M

DNA Discussion

View Posts
Monksdream Monksdream 2 days ago
DNA still climbing
👍️0
Monksdream Monksdream 2 weeks ago
DNA
👍️0
ItsMyOption ItsMyOption 1 month ago
DNA just hit over sold area $8.70 that is .22 before the 1:40 R/S should go back up $11.00 soon
👍️0
Monksdream Monksdream 2 months ago
DNA under $10
👍️0
Monksdream Monksdream 2 months ago
DNA, 10 day hourly
👍️ 1
PonkenPlonken PonkenPlonken 2 months ago
cheap
👍️0
Monksdream Monksdream 4 months ago
DNA under $10
👍️0
Monksdream Monksdream 5 months ago
DNA 10 day hourly post reverse split
👍️0
hwang_jini hwang_jini 5 months ago
Cascade (Gates) top holder
👍️0
Monksdream Monksdream 5 months ago
DNA new. 52 w eek low
👍️0
Monksdream Monksdream 5 months ago
DNA new 52/week low
👍️0
Monksdream Monksdream 6 months ago
DNA new 52 week low
👍️0
Monksdream Monksdream 6 months ago
DNA new 52 week low
👍️0
ItsMyOption ItsMyOption 6 months ago
even after 1:40 R/S DNA still has too many shares outstanding and corporate insiders have poorly mismanaged the company.
Ginkgo Bioworks needs complete restructure and less corporate greed. Some of their founders sell shares daily as they where gifted too many.
I stopped buying long ago and waiting to see if management can get their act together - they all deserve a pay cut!
👍️ 1
Monksdream Monksdream 6 months ago
DNA new 52 low
👍️0
Dingbatt Dingbatt 6 months ago
Interesting stock bought a few for tracking
To see what the crawdads do
👍️0
ItsMyOption ItsMyOption 6 months ago
poor management as they falsely pumped this stock now passing R/S effective Aug. 20
They also know they committed fraud and had to pass = 2. Officer Exculpation Proposal

Item 2 was to approve Article VIII of the Company’s Amended and Restated Certificate of Incorporation to permit officer exculpation (the “Officer Exculpation Proposal”), designated to be voted upon by the holders of Class A common stock and Class B common stock, voting together as a single class. The results of the vote were as follows:

exculpation
noun
a defense of some offensive behavior or some failure to keep a promise etc.
his transparent self-justification was unacceptable
the act of freeing from guilt or blame
👍️0
hwang_jini hwang_jini 7 months ago
bio scam….

https://www.prnewswire.com/news-releases/ginkgo-bioworks-to-hold-special-meeting-of-shareholders-302210173.html
👍️0
Acme Investments Acme Investments 8 months ago
Sometimes I wonder if big names get kickbacks in exchange for their names being used??
👍️0
Acme Investments Acme Investments 8 months ago
Cathy led her sheep 🐑 to slaughter!! Worst performing IPO I've ever seen!!
👍️ 1
Acme Investments Acme Investments 8 months ago
😂😂😂😂😂😂😂
👍️0
trade2brich trade2brich 8 months ago
ARK dumped all holdings. I am out. Cut my losses.
👍️0
Monksdream Monksdream 8 months ago
It will reverse split because there is no choice
👍️0
JohnnyBlaze JohnnyBlaze 8 months ago
Average down or cut losses?
👍️0
Monksdream Monksdream 8 months ago
DNA new 52 week low
👍️0
Acme Investments Acme Investments 8 months ago
Timber!!
👍️0
JohnnyBlaze JohnnyBlaze 8 months ago
Bought a few
👍️0
Acme Investments Acme Investments 8 months ago
R/S will be announced without warning!! Proceed with caution!!
👍️ 1
ItsMyOption ItsMyOption 8 months ago
Yes, new low and very unhappy with DNA management. They were too slow to start restructuring and they still have one of the founders selling stock daily - what does he know?
👍️0
Monksdream Monksdream 8 months ago
DNA new 52 week low
👍️0
Stump Jumper Stump Jumper 8 months ago
I appreciate the response and opinion. I would like to think we would get a small bounce upward from here before a possible RS....
👍️0
philaya philaya 8 months ago
Got in low...
Bounce ready.
👍️0
ItsMyOption ItsMyOption 9 months ago
I feel we are close to bottom possible around.50 as lots of shorts took this down fast. We know DNA is in restructuring mode, which they should have done a long time ago. We still have one of their founders selling shares daily which should be in their ethic guidance as he most likely has inside info on R/S soon.

Long term I am positive but unhappy with management.
👍️0
Stump Jumper Stump Jumper 9 months ago
Is this the bottom?
👍️0
Acme Investments Acme Investments 9 months ago
Acknowledge Me!! Lol 😂
👍️0
wiredawg wiredawg 9 months ago
Yep, yet another SPAC born public company that's in the toilet, I fore see a reverse announcement coming very soon, given they've received a listing standard Notice form the NYSE...
👍️0
Monksdream Monksdream 9 months ago
DNA new 52 week low
👍️0
Acme Investments Acme Investments 9 months ago
I'll take that as a no!! Lol 😂 The Cathy curse continues!!
👍️0
Acme Investments Acme Investments 9 months ago
Still happy??
👍️0
ItsMyOption ItsMyOption 9 months ago
Why DNA will keep going down is all the insider selling from page 43 of last finacials: Austin has been selling shares daily so it is founders driving the price below SEC requirements of min of $1.00
Ginkgo’s Founders currently own nearly 20% of the outstanding shares of Ginkgo, the vast majority of which are in Class B shares
? Class B shares are not freely tradable (must be converted to Class A) and are often not shown on automated data services
? As such, these aggregation services (such as Bloomberg or Yahoo) can be unhelpful in determining actual holdings of certain investors, including
our Founders, who may hold different classes of shares which may not be included

Founder sales through April 29, 2024 relative to total holdings(1)
Mandatory Sell-to-Cover(2) 10b5-1 plan
Shares sold
(in millions) % of holdings
Shares sold
(in millions) % of holdings
Jason (CEO) 12.3 11.3% 10.4 9.6%
Reshma (COO) 12.3 11.4% 1.9 1.8%
Barry (CTO) 12.3 11.2% 1.9 1.7%
Austin 12.3 11.3% 0.9 0.8
👍️0
Acme Investments Acme Investments 9 months ago
Hope you took profits!! They just wanted to burn the shorts!!
👍️0
Acme Investments Acme Investments 9 months ago
That's a lot of risk for 30%......Eventually you'll get snake eyes!!
👍️0
trade2brich trade2brich 9 months ago
Bought at .70….up 30%
👍️0
Acme Investments Acme Investments 9 months ago
Don't know if you noticed but Cathy has lost her MOJO and her investors a lot of money!! Proceed with caution ⚠!!
👍️0
trade2brich trade2brich 9 months ago
ARK bought 12 million shares on Friday
👍️0
Acme Investments Acme Investments 9 months ago
Ark is like the cattle whisperer!! Slaughter awaits!!
👍️0
Monksdream Monksdream 10 months ago
DNA new 52 week low
👍️0
Monksdream Monksdream 10 months ago
Aren’t you the smart one

👍️0
trade2brich trade2brich 10 months ago
I did not I keep buying
👍️0
Monksdream Monksdream 10 months ago
No, you buy
New 52 week lo
👍️0

Your Recent History

NYSE
DNA
Ginkgo Bioworks
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads